Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
6.73
-0.08 (-1.17%)
At close: Oct 30, 2026, 4:00 PM EDT
6.29
-0.44 (-6.54%)
After-hours: Oct 30, 2026, 7:31 PM EDT
Evommune Market Cap
Evommune has a market cap or net worth of $244.25 million as of October 30, 2026. It is the 19,310th most valuable company in the world and the 3,399th biggest in the United States.
Market Cap
244.25M
Enterprise Value
52.08M
1-Year Change
n/a
Global Rank
Country Rank
#3,399 United States
Category
ChartMarket Cap Chart
Since the IPO on November 6, 2025, Evommune's market cap has decreased from $481.24M to $244.25M, a decrease of -49.25%. That is a compound annual growth rate of -49.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 244.25M | -54.74% |
| Dec 31, 2025 | 539.69M | 12.15% |
| Nov 6, 2025 | 481.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lineage Cell Therapeutics | 254.17M |
| Abeona Therapeutics | 252.18M |
| Immuneering | 250.06M |
| Cabaletta Bio | 249.74M |
| InflaRx | 249.05M |
| Lexeo Therapeutics | 247.36M |
| Fate Therapeutics | 246.83M |
| Ocugen | 241.45M |